Upload Avatar (500 x 500)
Ming Lu
Basic Medical Sciences
Nanjing Medical University
Jiangsu
Language: Chinese, English
Neuropsychopharmacology
Neurodegenerative
Depression
Drug Targets
Pathogenesis
Neuroinflammation
Astrocytes
Parkinson'S Disease
Neuroprotection
Molecular Mechanisms
Areas of Focus
- Neuropsychopharmacology
- Mechanisms of neurodegenerative diseases
- Depression pathogenesis and drug targets
Work Experience
- 2020-present: Professor and Doctoral Supervisor, Department of Pharmacology, Nanjing Medical University
- 2019-2020: Associate Professor and Doctoral Supervisor, Department of Pharmacology, Nanjing Medical University
- 2015-2019: Associate Professor and Master's Supervisor, Department of Pharmacology, Nanjing Medical University
- 2011-2015: Lecturer, Department of Pharmacology, Nanjing Medical University
- 2007-2010: Research Assistant, Department of Pharmacology, National University of Singapore
Academic Background & Achievements
- 2006-2011: PhD in Pharmacology, Nanjing Medical University
- 2001-2006: Bachelor's in Clinical Medicine, Wannan Medical College
- Recipient of the National Excellent Young Scientist Fund
- Director of Jiangsu Key Laboratory of Neurodegenerative Diseases
Publications
- CircEPS15, as a sponge of MIR24-3p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy., Yuanzhang Zhou, Yang Liu, Zhengwei Kang, Hang Yao, Nanshan Song, Min Wang, Chenghuan Song, Kezhong Zhang, Jianhua Ding, Juanjuan Tang, Gang Hu, Ming Lu, 2023
- The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson's disease via LCN2-dependent astrocyte senescence., Si-Yuan Jiang, Tian Tian, Hang Yao, Xiao-Mei Xia, Cong Wang, Lei Cao, Gang Hu, Ren-Hong Du, Ming Lu, 2023
- Impeding the combination of astrocytic ASCT2 and NLRP3 by Talniflumate alleviates neuroinflammation in experimental models of Parkinson’s disease., Yang Liu, Ting Liu, Yuanzhang Zhou, Wenjie Li, Min Wang, Nanshan Song, Wenbin Zhang, Jingwei Jiang, Shengtao Yuan, Jianhua Ding, Gang Hu, Ming Lu, 2023
- Mefloquine targets NLRP3 to reduce lipopolysaccharide-induced systemic inflammation and neural injury., Si-Yuan Jiang, Tian Tian, Wen-Jie Li, Ting Liu, Cong Wang, Gang Hu, Ren-Hong Du, Yang Liu, Ming Lu, 2023
- JWA binding to NCOA4 alleviates degeneration in dopaminergic neurons through suppression of ferritinophagy in Parkinson's disease., Xinxin Zhao, Zhengwei Kang, Ruixue Han, Min Wang, Yueping Wang, Xin Sun, Cong Wang, Jianwei Zhou, Lei Cao, Ming Lu, 2024
Awards
- 2023: Second Prize in Natural Science, Ministry of Education
- 2023: Second Prize in Jiangsu Science and Technology Award
- 2023: Jiangsu Province Excellent Science and Technology Innovation Team
- 2021: First Prize in Jiangsu Higher Education Science and Technology Research
- 2016: Second Prize in Jiangsu Education Science Research
- 2018: Jiangsu 'Six Talent Peaks' A-Class High-Level Talent
- 2018: Jiangsu '333 Talent Project' Third Level
- 2013: Excellent Young Pharmacologist Award, Chinese Pharmacological Society
- 2022: Jiangsu Youth May Fourth Medal
